Study title:
Declèves X, Niel E, Debray M, Scherrmann J-M. Is P-glycoprotein (ABCB1) a phase 0 or a phase 3 colchicine transporter depending on colchicine exposure conditions? Toxicology and Applied Pharmacology 2006; 217:153-160Declèves X, Niel E, Debray M, Scherrmann J-M. Is P-glycoprotein (ABCB1) a phase 0 or a phase 3 colchicine transporter depending on colchicine exposure conditions? Toxicology and Applied Pharmacology 2006; 217:153-160
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: COLCHICINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|